Scholars@Duke

Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia.

Publication ,  Journal Article
Thomas, MB; Koller, C; Yang, Y; Shen, Y; O'Brien, S; Kantarjian, H; Davis, J; Estey, E
Published in: Leukemia
May 2003
Published version (DOI) Link to item

Duke Scholars

Melanie Byrne Thomas
Author Melanie Byrne Thomas Medicine, Medical Oncology

Published In

Leukemia

DOI

10.1038/sj.leu.2402862

ISSN

0887-6924

Publication Date

May 2003

Volume

17

Issue

5

Start / End Page

990 / 993

Location

England

Related Subject Headings

  • Vidarabine
  • Treatment Outcome
  • Salvage Therapy
  • Remission Induction
  • Neoplasm Recurrence, Local
  • Middle Aged
  • Leukemia, Myeloid
  • Immunology
  • Humans
  • Drug Administration Schedule
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, M. B., Koller, C., Yang, Y., Shen, Y., O’Brien, S., Kantarjian, H., … Estey, E. (2003). Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. Leukemia, 17(5), 990–993. https://doi.org/10.1038/sj.leu.2402862
Thomas, M. B., C. Koller, Y. Yang, Y. Shen, S. O’Brien, H. Kantarjian, J. Davis, and E. Estey. “Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia.” Leukemia 17, no. 5 (May 2003): 990–93. https://doi.org/10.1038/sj.leu.2402862.
Thomas MB, Koller C, Yang Y, Shen Y, O’Brien S, Kantarjian H, et al. Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. Leukemia. 2003 May;17(5):990–3.
Thomas, M. B., et al. “Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia.” Leukemia, vol. 17, no. 5, May 2003, pp. 990–93. Pubmed, doi:10.1038/sj.leu.2402862.
Thomas MB, Koller C, Yang Y, Shen Y, O’Brien S, Kantarjian H, Davis J, Estey E. Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. Leukemia. 2003 May;17(5):990–993.

Published In

Leukemia

DOI

10.1038/sj.leu.2402862

ISSN

0887-6924

Publication Date

May 2003

Volume

17

Issue

5

Start / End Page

990 / 993

Location

England

Related Subject Headings

  • Vidarabine
  • Treatment Outcome
  • Salvage Therapy
  • Remission Induction
  • Neoplasm Recurrence, Local
  • Middle Aged
  • Leukemia, Myeloid
  • Immunology
  • Humans
  • Drug Administration Schedule